beta-Rubromycin (CAS: 27267-70-5)

Rubromycins are actinobacterial aromatic polyketides featuring a hallmark spiroketal pharmacophore. Classic enzymology showed that α- and β-rubromycin reversibly inhibit HIV-1 reverse transcriptase with competitive interaction versus template-primer, and noncompetitive behavior versus nucleotide substrate, indicating blockade of nucleic acid binding and processing rather than general polymerase poisoning. Separately, rubromycins inhibit human telomerase with micromolar potency, and structure-activity studies demonstrated that opening the spiroketal system drastically reduces telomerase inhibition, establishing the spiroketal as a key pharmacophore. More recent genome-mining expanded the rubromycin family, for example through discovery of coumarubrin, reinforcing that these metabolites arise from type II polyketide synthase pathways and can be diversified by tailoring enzymes to yield new antibacterial profiles.